Company intelligence / Profile preview

Pronacera Therapeutics

Sevilla, Andalusia, Spainpronacera.com ↗

Ownership: Private
Development stage: Other

Overview

Pronacera Therapeutics develops advanced genetic diagnostic tools and biotechnological treatments focused on reproductive health, rare diseases without current effective diagnostics or therapies, inflammatory conditions, and general health. Their offerings include proprietary platforms for drug screening in lysosomal/mitochondrial/NBIA/hypercholesterolemia disorders as well as personalized medicine services such as cardiovascular genetics. The company also holds patents related to apoptotic cell stabilizers and methods to evaluate drug effectiveness in mitochondrial diseases/MELAS syndrome. They collaborate with academic groups at University Pablo de Olavide.

Therapeutic areas: Rare DiseasesNeurologyWomen's HealthImmunologyRheumatologyCardiovascular
Modalities: Genetic diagnostic toolsSmall moleculeBiologicDiagnostic test/service
Industry: Biotech

Partnerships

HeartGenetics

Beyond the preview

Go deeper on Pronacera Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pronacera Therapeutics.

Explore the full profile